Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-25-001347
Filing Date
2025-08-14
Accepted
2025-08-14 17:07:16
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q g084907_10q.htm   iXBRL 10-Q 856249
2 EXHIBIT 31.1 g084907_ex31-1.htm EX-31.1 9398
3 EXHIBIT 31.2 g084907_ex31-2.htm EX-31.2 9283
4 EXHIBIT 32.1 g084907_ex32-1.htm EX-32.1 4830
5 EXHIBIT 32.2 g084907_ex32-2.htm EX-32.2 4847
  Complete submission text file 0001753926-25-001347.txt   4544273

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20250630.xsd EX-101.SCH 41204
7 XBRL CALCULATION FILE lipo-20250630_cal.xml EX-101.CAL 40518
8 XBRL DEFINITION FILE lipo-20250630_def.xml EX-101.DEF 133469
9 XBRL LABEL FILE lipo-20250630_lab.xml EX-101.LAB 337566
10 XBRL PRESENTATION FILE lipo-20250630_pre.xml EX-101.PRE 259970
71 EXTRACTED XBRL INSTANCE DOCUMENT g084907_10q_htm.xml XML 596664
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41575 | Film No.: 251220843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)